ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 687523 Null 0.0348993771550531 -0.0084455433
NSC 694509 Null 0.0348993771550531 0.033492662
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0348993771550531 0.42376988
NSC 711077 Null 0.0348993771550531 0.025604502
NSC 718630 Null 0.0348993771550531 0.59745409
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0348993771550531 -0.17458403
NSC 720497 Null 0.0348993771550531 -0.17296413
NSC 725098 Null 0.0348993771550531 0.22058097
NSC 726578 Null 0.0348993771550531 0.051811004
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0348993771550531 0.12102661
Total:119  Current:78    [First] [Prev] [Next] [Last]